Gromeier, M., Alexander, L., & Wimmer, E. (1996). Substitution of the poliovirus IRES with its counterpart from human rhinovirus type 2 mediates loss of neurovirulence. In F. Brown, E. Norrby, D. Burton, & J. Mekalanos (Eds.), VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES (pp. 19–25). COLD SPRING HARBOR, NY: COLD SPRING HARBOR LABORATORY PRESS.

Gromeier, M., L. Alexander, and E. Wimmer. “Substitution of the poliovirus IRES with its counterpart from human rhinovirus type 2 mediates loss of neurovirulence.” In VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, edited by F. Brown, E. Norrby, D. Burton, and J. Mekalanos, 19–25. COLD SPRING HARBOR LABORATORY PRESS, 1996.

Gromeier M, Alexander L, Wimmer E. Substitution of the poliovirus IRES with its counterpart from human rhinovirus type 2 mediates loss of neurovirulence. In: Brown F, Norrby E, Burton D, Mekalanos J, editors. VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES. COLD SPRING HARBOR LABORATORY PRESS; 1996. p. 19–25.

Gromeier, M., et al. “Substitution of the poliovirus IRES with its counterpart from human rhinovirus type 2 mediates loss of neurovirulence.” VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, edited by F. Brown et al., COLD SPRING HARBOR LABORATORY PRESS, 1996, pp. 19–25.

Gromeier M, Alexander L, Wimmer E. Substitution of the poliovirus IRES with its counterpart from human rhinovirus type 2 mediates loss of neurovirulence. In: Brown F, Norrby E, Burton D, Mekalanos J, editors. VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES. COLD SPRING HARBOR LABORATORY PRESS; 1996. p. 19–25.